Final Programme

116
Posters Physicians Tuesday, 31 March 2009
17:30– Infectious complications (continued)
19:00
P877 Rota- and calicivirus infections following allogeneic haematopoetic stem cell
transplantation
K. Kállay, J. Sinkó, G. Benyó, Á. Tóth, V. Goda, G. Kriván (Budapest, HU)
P878 Preliminary monocentric survey on the prevalence of HBV seropositivity in HSCT
recipients
P. Usardi, C. Annaloro, M. Viganò, P. Lampertico, F. Onida, E. Tagliaferri, A. Della Volpe,
G. Lambertenghi Deliliers (Milan, IT)
P879 Catheter-related infections in tunnelled central venous devices in haematologic
malignancies and haematopoietic stem cell transplantation patients.
A single-centre experience
E. Carrillo Cruz, J. Falantes González, J. González Campos, M. Ruiz Seixas, A. Urbano
Ispizua, I. Espigado Tocino (Sevilla, ES)
P880 High efficacy and low toxicity of short-course oral valganciclovir given as
one-week BID treatment and one-week QD maintenance as pre-emptive
therapy for post-HSCT CMV infection
A.J.M. Saleh, F. Al-Mohareb, F. Al-Rabiah, N. Chaudhri, F. Al-Sharif, H. Al-Zahrani,
S. Mohamed, K. Al-Anazi, M. Patel, W. Rasheed, A. Elghazaly, M. Bakr, S. Ahmed,
A. Nassar, F. Hussain, Z. Nurgat, H. Al-Abdely, M. Aljurf (Riyadh, SA)
P881 Peripherally inserted central venous catethers in the management of autologous
haematopoietic stem cell transplantation
S. Bellesi, G. De Pascale, P. Chiusolo, G. Scoppettuolo, M. Pittiruti, F. Sorà, L. Laurenti,
G. Leone, S. Sica (Rome, IT)
P882 Frequency and mains causes of the febrile episodes during myeloablative
chemotherapy neutropenia induced after bone marrow transplant
A. Talbi, R. Ahmed Nacer, M. Benakli, R. Belhadj, F. Mehdid, M. Baazizi, N. Rahmoune,
K. Saidani, D. Ait Ouali, S. Madene, S. Abderrahmani, R.M. Hamladji (Algiers, DZ)
P883 Cytomegalovirus DNAemia and treatment following allogeneic stem cell
transplantation with focus on long-term outcome
J. Lindahl (Göteborg, SE)
P884 Emergence of uncommon infection in bone marrow transplantation:
the modern Trojan horse?
T. Zuckerman, N. Benyamini, N. Haddad, R. Fineman, I. Avivi, E. Sabo, J.M. Rowe, I. Oren
(Haifa, IL)
P885 Invasive fungal infection in patients after allogeneic haematopoietic stem cell
transplantation. A single-centre experience
N. Zubarovskaya , Y. Vasilieva, E. Semenova, N. Stancheva , E. Morozova, N. Klimko,
A. Chukhlovin , B. Afanasyev (St. Petersburg, RU)
P886 The utility of screening swabs in allogeneic haematopoeitic stem cell transplant
recipients: a retrospective evaluation
S. Ager, N. Young, H. Inns, G. Cook, M. Gilleece, S. Liebersbach, G. Shenton, T. Collyns
(Leeds, UK)
P887 Posaconazole has superior clinical efficacy and cost-effectiveness to
itraconazole for antifungal prophylaxis in allogeneic stem cell transplant
recipients: a single-centre experience
R.F. Duarte, B. Patiño, C. Muñoz, M. Arnan, T. Peralta, C. Gudiol, I. Sánchez-Ortega,
R. Parody, A. Clopés, J.L. López-Belmonte, F.J. Sabater, A. Fernández de Sevilla
(Barcelona, Madrid, ES)
P888 Is serological or PCR positivity of Toxoplasma gondii in donor or recipient the
reason for haematopoietic stem cell transplantation delay?
L. Krol, M. Matulova, P. Hubacek, P. Keslova, R. Formankova, P. Sedlacek (Prague, CZ)